Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apalutamide vs ADT with Salvage Radiotherapy in Prostate Cancer
NCT03899077Phase 2Recruiting
- Sponsor
- Center for Oncological Research
- Start
- Apr 2019
- Primary completion
- Aug 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of apalutamide in prostate cancer (PCa), sponsored by Center for Oncological Research. Started Apr 2019; status: recruiting.
02
Drugs
apalutamide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03899077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03899077.